세계 양성자 치료 시스템 시장 - 셋업 유형별, 적응증별, 최종 용도별 예측(-2032년)

Proton therapy system market size is expected to record more than 10.5% CAGR from 2023 to 2032 due to the technological advancements that lead to improved results. For instance, pencil beam scanning and intensity-modulated proton therapy have enhanced treatment precision and expanded the range of treatable conditions. In October 2023, Mevion Medical Systems launched 'Mevion Capital' in US and Canada, a compact proton therapy system for use in radiation therapy of cancer.

Furthermore, the lower risk of radiation-induced complications and minimal damage to healthy tissues make proton therapy a preferred choice for both pediatric and adult patients. This has led to increased adoption and demand for proton therapy systems worldwide. The expanding pool of cancer patients and supportive reimbursement policies further influence the market growth trajectory.

The overall proton therapy systems market is divided based on set-up type, indication, end-use, and region.

The multiple room set-up type segment is predicted to witness substantial growth through 2032 due to their ability to treat more patients efficiently, reducing waiting times and providing a better healthcare experience. Such facilities are equipped with multiple treatment rooms and enable healthcare providers to cater to a larger patient population. As healthcare facilities continue to invest in expanding their proton therapy capabilities, the product demand will increase.

The proton therapy center end-use segment is anticipated to generate massive revenues by 2032 as these dedicated centers offer comprehensive proton therapy services to patients, ensuring the highest quality of care. Proton therapy centers are playing a crucial role in the fight against cancer, and their numbers are on the rise. They offer a range of treatment options and are often equipped with state-of-the-art technology, making them a key contributor to the market expansion.

Asia Pacific proton therapy systems market will record strong CAGR from 2023 to 2032 attributed to the growing prevalence of cancer, increasing healthcare infrastructure development, and rising medical expenditure in countries such as China, Japan, and South Korea. With a focus on enhancing cancer treatment options, the APAC region is witnessing a surge in the establishment of proton therapy centers. These centers are equipped with the latest proton therapy systems, facilitating access to advanced cancer treatments for the population in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & workings
• 1.3 Forecast calculations
• 1.4 Data Sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Global proton therapy systems market 360 degree synopsis, 2018 - 2032
• 2.2 Regional trends (Revenue & Volume)
• 2.3 Set-up type trends
• 2.4 Indication trends
• 2.5 End-use trends

Chapter 3 Proton Therapy Systems Industry Insights

• 3.1 COVID- 19 impact analysis
• 3.2 Industry ecosystem analysis
• 3.3 Technology landscape
• 3.4 Regulatory landscape
• 3.5 Industry impact forces
  • 3.5.1 Growth drivers
    • 3.5.1.1 Increasing prevalence of cancer
    • 3.5.1.2 Growing awareness and diagnosis rates
    • 3.5.1.3 Increasing number of proton therapy offered by many medical establishments
    • 3.5.1.4 Technological advancements
  • 3.5.2 Industry pitfalls & challenges
    • 3.5.2.1 High cost of the device and procedure
    • 3.5.2.2 Availability of alternative treatment approaches
• 3.6 Growth potential analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
  • 4.1.1 IBA worldwide
  • 4.1.2 Hitachi
  • 4.1.3 Mevion Medical Systems
• 4.2 Competitive analysis of major market players, 2022
• 4.3 Competitive positioning matrix, 2022
• 4.4 Strategic outlook matrix, 2022

Chapter 5 Proton Therapy Systems Market Estimates and Forecast, By Set-up Type (Revenue)

• 5.1 Key trends, by set-up type
• 5.2 Single room
• 5.3 Multiple room

Chapter 6 Proton Therapy Systems Market Estimates and Forecast, By Indication (Revenue)

• 6.1 Key trends, by indication
• 6.2 Breast cancer
• 6.3 Lung cancer
• 6.4 Prostate cancer
• 6.5 Gastro-intestinal cancer
• 6.6 Brain cancer
• 6.7 Others

Chapter 7 Proton Therapy Systems Market Estimates and Forecast, By End-use (Revenue)

• 7.1 Key trends, by end-use
• 7.2 Hospitals
• 7.3 Proton therapy centers
• 7.4 Others

Chapter 8 Proton Therapy Systems Market Estimates and Forecast, By Region (Revenue)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Switzerland
  • 8.3.7 The Netherlands
  • 8.3.8 Denmark
  • 8.3.9 Poland
  • 8.3.10 Sweden
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 New Zealand
  • 8.4.7 Thailand
  • 8.4.8 Vietnam
  • 8.4.9 Indonesia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Colombia
  • 8.5.5 Chile
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Turkey

Chapter 9 Company Profiles

• 9.1 IBA worldwide
• 9.2 Hitachi
• 9.3 Mevion Medical Systems
• 9.4 Optivus Proton Therapy
• 9.5 Advanced Oncotherapy plc
• 9.6 Mitsubishi Electric Corporation
• 9.7 Varian
• 9.8 Ion Beam Applications SA
• 9.9 ProTom International
• 9.10 Provision Healthcare